According to IMARC Group’s latest report, titled “Lymphoma Treatment Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global lymphoma treatment market grew at a CAGR of around 8% during 2015-2020. Looking forward, the market is expected to continue its moderate growth during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Lymphoma stands for a type of cancer that affects the lymphatic system and impairs the body’s immune response. It targets the lymphocytes or white blood cells in the lymph nodes, bone marrow, thymus, and spleen. Lymphoma causes swelling in the lymph nodes, weight loss, fatigue, high fever, and dyspnea. The two main types of this disease are Hodgkin and non-Hodgkin lymphoma. Some common lymphoma treatments include chemotherapy, radiation therapy, bone marrow transplant, active surveillance, monoclonal antibody therapy, immunotherapy drugs, etc.
Request Free Sample Report: https://www.imarcgroup.com/lymphoma-treatment-market/requestsample
A significant growth in the healthcare sector, coupled with the increasing geriatric population, who are more prone to lymphoma, are also augmenting the global market. Additionally, rising consumer health awareness and the emergence of innovative treatment alternatives and diagnostic technologies, such as immune checkpoint inhibitors, are also augmenting the market growth. Several healthcare centers and hospitals are getting inclined towards advanced imaging technologies, such as Magnetic Resonance Imaging (MRI), computed tomography (CT), and positron emission tomography (PET) scans for timely detection and respective treatment of cancer cells. Moreover, the rising investments in extensive research and development activities in the healthcare industry are further expected to bolster the global market for lymphoma treatment in the coming years.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://bit.ly/30F3Vb6
List of Key Companies Covered in this Market Report:
- Abbott Laboratories (NYSE: ABT)
- Bristol-Myers Squibb Company (NYSE: BMY)
- Eli Lilly and Company (NYSE: LLY)
- Hoffmann-La Roche Ltd (SWX: RO)
- Johnson & Johnson (NYSE: JNJ)
- Merck & Co. Inc. (NYSE: MRK)
- Novartis AG (SWX: NOVN)
- Spectrum Pharmaceuticals (NASDAQ: SPPI)
- Takeda Pharmaceutical Company Ltd (TYO: 4502)
- Teva Pharmaceutical Industries Ltd (TLV: TEVA)
The report has segmented the market on the basis of type, test type, drug and geography
Breakup by Type:
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
Breakup by Test Type:
- Radiation Therapy
- Targeted Therapy
- Biologic Therapy
Breakup by Drug:
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800